Qingdao NovelBeam Technology Co. Ltd. A (688677) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥16.62 Million ≈ $2.43 Million USD) by net assets (CN¥1.26 Billion ≈ $184.29 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qingdao NovelBeam Technology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688677 liabilities breakdown for a breakdown of total debt and financial obligations.
Qingdao NovelBeam Technology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao NovelBeam Technology Co. Ltd. A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Apex Dynamics Inc.
TW:4583
|
0.022x |
|
Staidson Beijing Biopharma
SHE:300204
|
-0.046x |
|
Jiangxi Hongcheng Waterworks Co Ltd
SHG:600461
|
0.058x |
|
Wuxi Dk Electronic Materials Co Ltd
SHE:300842
|
0.002x |
|
Cal-Comp Electronics (Thailand) Public Company Limited
TW:9105
|
0.024x |
|
Stolt-Nielsen Limited
LSE:0OHK
|
0.058x |
|
Poya International Co Ltd
TWO:5904
|
0.151x |
|
ST Pharm Co.Ltd
KQ:237690
|
-0.036x |
Annual Cash Flow Conversion Efficiency for Qingdao NovelBeam Technology Co. Ltd. A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Qingdao NovelBeam Technology Co. Ltd. A (688677) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.31 Billion ≈ $191.03 Million |
CN¥112.32 Million ≈ $16.44 Million |
0.086x | -29.65% |
| 2023-12-31 | CN¥1.29 Billion ≈ $189.17 Million |
CN¥158.12 Million ≈ $23.14 Million |
0.122x | +43.26% |
| 2022-12-31 | CN¥1.22 Billion ≈ $178.89 Million |
CN¥104.38 Million ≈ $15.27 Million |
0.085x | -10.13% |
| 2021-12-31 | CN¥1.09 Billion ≈ $160.20 Million |
CN¥104.01 Million ≈ $15.22 Million |
0.095x | -73.54% |
| 2020-12-31 | CN¥319.69 Million ≈ $46.78 Million |
CN¥114.78 Million ≈ $16.80 Million |
0.359x | -3.39% |
| 2019-12-31 | CN¥224.80 Million ≈ $32.90 Million |
CN¥83.54 Million ≈ $12.22 Million |
0.372x | +76.39% |
| 2018-12-31 | CN¥229.45 Million ≈ $33.58 Million |
CN¥48.34 Million ≈ $7.07 Million |
0.211x | -38.23% |
| 2017-12-31 | CN¥193.68 Million ≈ $28.34 Million |
CN¥66.06 Million ≈ $9.67 Million |
0.341x | +32.46% |
| 2016-12-31 | CN¥142.21 Million ≈ $20.81 Million |
CN¥36.62 Million ≈ $5.36 Million |
0.257x | +52.17% |
| 2015-12-31 | CN¥94.77 Million ≈ $13.87 Million |
CN¥16.04 Million ≈ $2.35 Million |
0.169x | -14.27% |
| 2014-12-31 | CN¥69.64 Million ≈ $10.19 Million |
CN¥13.75 Million ≈ $2.01 Million |
0.197x | -42.75% |
| 2013-12-31 | CN¥63.19 Million ≈ $9.25 Million |
CN¥21.79 Million ≈ $3.19 Million |
0.345x | -- |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more